Bruce Johnson, MD
Rheumatology · Elk Grove Village, ILNPI 1912043621
Payments from drug & device makers
Across 754 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- AbbVie$2K
- UCB, Inc.$1K
- Pfizer$923
- Novartis$863
- GSK$823
- plus $5K from 26 others
What the payments were for
- Food & beverage$14,61699%
- Education$801%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 171 | $3,309 |
| AbbVie | 144 | $2,111 |
| UCB, Inc. | 81 | $1,465 |
| Pfizer | 44 | $923 |
| Novartis | 58 | $863 |
| GSK | 37 | $823 |
| Johnson & Johnson(3 entities) | 36 | $733 |
| Lilly USA, LLC | 35 | $719 |
| E.r. Squibb & Sons, L.L.C. | 26 | $534 |
| AstraZeneca(2 entities) | 22 | $497 |
| Boehringer Ingelheim | 17 | $494 |
| Sanofi | 17 | $393 |
| Janssen Scientific Affairs, LLC | 2 | $290 |
| Fresenius Kabi USA, LLC | 9 | $247 |
| Aurinia Pharma U.S., Inc. | 6 | $241 |
| Radius Health, Inc. | 10 | $178 |
| Genentech USA, Inc. | 7 | $150 |
| Actelion Pharmaceuticals US, Inc. | 5 | $94 |
| Mallinckrodt Hospital Products Inc. | 3 | $79 |
| Hikma Pharmaceuticals USA | 4 | $67 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $63 |
| Sandoz | 3 | $58 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $52 |
| Organon | 2 | $50 |
| ANI Pharmaceuticals, Inc. | 2 | $50 |
| Bristol Myers Squibb | 2 | $46 |
| Bioventus LLC | 1 | $40 |
| Sobi, Inc | 1 | $29 |
| Hospira, Inc. | 1 | $27 |
| Pacira Therapeutics, Inc. | 1 | $26 |
| Medexus Pharma, Inc. | 2 | $25 |
| Biocon Biologics Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,696 in reported general payments places this provider in the 75th percentile of 287 rheumatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 20 | $224,489 |
| Humira(Cf) PenAdalimumab | 22 | $163,453 |
| Humira PenAdalimumab | 17 | $128,332 |
| Xeljanz XrTofacitinib Citrate | 15 | $89,371 |
| MethotrexateMethotrexate Sodium | 576 | $13,507 |
| Hydroxychloroquine Sulfate | 401 | $12,494 |
| Leflunomide | 78 | $5,280 |
| Colchicine | 36 | $3,627 |
| Duloxetine Hcl | 187 | $3,103 |
| Celecoxib | 78 | $3,098 |
| Mycophenolate Mofetil | 70 | $2,410 |
| Prednisone | 343 | $2,326 |
| Pilocarpine Hcl | 33 | $1,936 |
| Allopurinol | 119 | $1,479 |
| Gabapentin | 59 | $1,420 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Elk Grove Village
- Manish JainChicago$36.5M
- Angela CrowleyWillowbrook$7.5M
- Robert HozmanSkokie$3.2M
- Robert TrappSpringfield$1.8M
- Lori SiegelBannockburn$1.5M
- Kamran ChaudharySchaumburg$1.4M
- Ira FentonLibertyville$678K
- Alfonso BelloGlenview$642K
- Theodore PincusChicago$524K
- Saad TariqRockford$510K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.